Dermapharm Holding SE
DUS:DMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dermapharm Holding SE
DUS:DMP
|
DE |
Dermapharm Holding SE
Dermapharm Holding SE is a German pharmaceutical company that develops, manufactures, and sells branded medicines and health products. Its core business is patent-free drugs, over-the-counter remedies, dermatology products, allergy treatments, and some nutritional supplements. It also makes some products for other companies through contract manufacturing. The company sells mainly to pharmacies, wholesalers, doctors, and hospitals, which then reach patients and consumers. It earns money by selling its own brands and by producing medicines and healthcare products for third parties. In practice, Dermapharm sits in the middle of the value chain: it does the product development, owns the brands, and often controls manufacturing too. What sets Dermapharm apart is its focus on niche products that are hard to copy quickly, especially in skin care and allergy care. Instead of competing mainly on huge blockbuster drugs, it builds a portfolio of smaller branded products and specialty medicines that can generate steady demand from everyday medical use.
Dermapharm Holding SE is a German pharmaceutical company that develops, manufactures, and sells branded medicines and health products. Its core business is patent-free drugs, over-the-counter remedies, dermatology products, allergy treatments, and some nutritional supplements. It also makes some products for other companies through contract manufacturing.
The company sells mainly to pharmacies, wholesalers, doctors, and hospitals, which then reach patients and consumers. It earns money by selling its own brands and by producing medicines and healthcare products for third parties. In practice, Dermapharm sits in the middle of the value chain: it does the product development, owns the brands, and often controls manufacturing too.
What sets Dermapharm apart is its focus on niche products that are hard to copy quickly, especially in skin care and allergy care. Instead of competing mainly on huge blockbuster drugs, it builds a portfolio of smaller branded products and specialty medicines that can generate steady demand from everyday medical use.
